ASSET PURCHASE AGREEMENT by and between ACORDA THERAPEUTICS, INC. and CATALENT PHARMA SOLUTIONS, INC. Dated as of January 12, 2021Asset Purchase Agreement • March 16th, 2021 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
ASSET PURCHASE AGREEMENT, dated as of January 12, 2021 (this “Agreement”), by and between Acorda Therapeutics, Inc., a Delaware corporation (“Seller”), and Catalent Pharma Solutions, Inc., a Delaware corporation (“Purchaser”).
Manufacturing Services AgreementManufacturing Services Agreement • March 16th, 2021 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
In consideration of the rights conferred and the obligations assumed herein and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each Party), the Parties, intending to be legally bound, agree as follows:
